• Crospon (Galway, Ireland) received FDA approval to market its EndoFLIP imaging system in the U.S. for gastroenterology applications. According to the company, the system will be able to be used in gastrodiagnostics and bariatric surgery and to measure the dimensions in other hollow organs such as the stretching capacity of sphincters and valves. The EndoFLIP imaging system is the first product that Crospon is bringing to market. Crospon said it had added a new Barostat software option to EndoFLIP. Apparently this new option extends the FDA cleared uses for the EndoFLIP system beyond measurements taken during gastric band and sleeve gastrectomy bariatric surgery procedures. For instance, it means that EndoFLIP can also include pressure and dimension measurements taken in the esophagus.